List of Tables
    Table 1. Global Gastroesophageal Reflux Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Esomeprazole
    Table 3. Major Manufacturers of Lansoprazole
    Table 4. Major Manufacturers of Omeprazole
    Table 5. Major Manufacturers of Rbeprazole
    Table 6. Major Manufacturers of Dexlansoprazole
    Table 7. Major Manufacturers of Others
    Table 8. Global Gastroesophageal Reflux Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 9. Global Gastroesophageal Reflux Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 10. Global Gastroesophageal Reflux Drugs Sales by Regions (2016-2021) & (K Units)
    Table 11. Global Gastroesophageal Reflux Drugs Sales Market Share by Regions (2016-2021)
    Table 12. Global Gastroesophageal Reflux Drugs Revenue by Regions (2016-2021) & (US$ Million)
    Table 13. Global Gastroesophageal Reflux Drugs Sales Forecast by Region (2022-2027) & (K Units)
    Table 14. Global Gastroesophageal Reflux Drugs Sales Market Share Forecast by Region (2022-2027)
    Table 15. Global Gastroesophageal Reflux Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 16. Global Gastroesophageal Reflux Drugs Revenue Market Share Forecast by Region (2022-2027)
    Table 17. Global Gastroesophageal Reflux Drugs Sales by Manufacturers (2016-2021) (K Units)
    Table 18. Global Gastroesophageal Reflux Drugs Sales Share by Manufacturers (2016-2021)
    Table 19. Ranking of Global Top Gastroesophageal Reflux Drugs Manufacturers by Revenue (US$ Million) in 2020
    Table 20. Gastroesophageal Reflux Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 21. Gastroesophageal Reflux Drugs Revenue Share by Manufacturers (2016-2021)
    Table 22. Global Gastroesophageal Reflux Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 23. Global Gastroesophageal Reflux Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroesophageal Reflux Drugs as of 2020)
    Table 24. Key Manufacturers Gastroesophageal Reflux Drugs Price (2016-2021) (US$/Unit)
    Table 25. Gastroesophageal Reflux Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Gastroesophageal Reflux Drugs Product Type
    Table 27. Date of International Manufacturers Enter into Gastroesophageal Reflux Drugs Market
    Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 29. Global Gastroesophageal Reflux Drugs Sales by Type (2016-2021) (K Units)
    Table 30. Global Gastroesophageal Reflux Drugs Sales Share by Type (2016-2021)
    Table 31. Global Gastroesophageal Reflux Drugs Revenue by Type (2016-2021) (US$ Million)
    Table 32. Global Gastroesophageal Reflux Drugs Revenue Share by Type (2016-2021)
    Table 33. Gastroesophageal Reflux Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 34. Global Gastroesophageal Reflux Drugs Sales Forecast by Type (2022-2027) & (K Units)
    Table 35. Global Gastroesophageal Reflux Drugs Sales Market Share Forecast by Type (2022-2027)
    Table 36. Global Gastroesophageal Reflux Drugs Revenue Forecast V (2022-2027) & (US$ Million)
    Table 37. Global Gastroesophageal Reflux Drugs Revenue Market Share Forecast by Type (2022-2027)
    Table 38. Global Gastroesophageal Reflux Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 39. Global Gastroesophageal Reflux Drugs Sales by Application (2016-2021) (K Units)
    Table 40. Global Gastroesophageal Reflux Drugs Sales Share by Application (2016-2021)
    Table 41. Global Gastroesophageal Reflux Drugs Revenue by Application (2016-2021) (US$ Million)
    Table 42. Global Gastroesophageal Reflux Drugs Revenue Share by Application (2016-2021)
    Table 43. Gastroesophageal Reflux Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 44. Global Gastroesophageal Reflux Drugs Sales Forecast by Application (2022-2027) & (K Units)
    Table 45. Global Gastroesophageal Reflux Drugs Sales Market Share Forecast by Application (2022-2027)
    Table 46. Global Gastroesophageal Reflux Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 47. Global Gastroesophageal Reflux Drugs Revenue Market Share Forecast by Application (2022-2027)
    Table 48. Global Gastroesophageal Reflux Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 49. Japan Gastroesophageal Reflux Drugs Sales (K Units) of Key Companies (2016-2021)
    Table 50. Japan Gastroesophageal Reflux Drugs Sales Share by Company (2016-2021)
    Table 51. Japan Gastroesophageal Reflux Drugs Revenue (US$ Million) by Company (2016-2021)
    Table 52. Japan Gastroesophageal Reflux Drugs Revenue Share by Company (2016-2021)
    Table 53. Japan Gastroesophageal Reflux Drugs Sales (K Units) by Type (2016-2021)
    Table 54. Japan Gastroesophageal Reflux Drugs Sales Share by Type (2016-2021)
    Table 55. Japan Gastroesophageal Reflux Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 56. Japan Gastroesophageal Reflux Drugs Price (US$/Unit) by Type (2016-2021)
    Table 57. Japan Gastroesophageal Reflux Drugs Sales (K Units) by Type (2022-2027)
    Table 58. Japan Gastroesophageal Reflux Drugs Sales Share by Type (2022-2027)
    Table 59. Japan Gastroesophageal Reflux Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 60. Japan Gastroesophageal Reflux Drugs Revenue Share by Type (2022-2027)
    Table 61. Japan Gastroesophageal Reflux Drugs Price (US$/Unit) by Type (2022-2027)
    Table 62. Japan Gastroesophageal Reflux Drugs Sales (K Units) by Application (2016-2021)
    Table 63. Japan Gastroesophageal Reflux Drugs Sales Share by Application (2016-2021)
    Table 64. Japan Gastroesophageal Reflux Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 65. Japan Gastroesophageal Reflux Drugs Price (US$/Unit) by Application (2016-2021)
    Table 66. Japan Gastroesophageal Reflux Drugs Sales (K Units) by Application (2022-2027)
    Table 67. Japan Gastroesophageal Reflux Drugs Sales Share by Application (2022-2027)
    Table 68. Japan Gastroesophageal Reflux Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 69. Japan Gastroesophageal Reflux Drugs Revenue Share by Application (2022-2027)
    Table 70. Japan Gastroesophageal Reflux Drugs Price (US$/Unit) by Application (2022-2027)
    Table 71. North America Gastroesophageal Reflux Drugs Sales by Country (2016-2021) & (K Units)
    Table 72. North America Gastroesophageal Reflux Drugs Sales Market Share by Country (2016-2021)
    Table 73. North America Gastroesophageal Reflux Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 74. North America Gastroesophageal Reflux Drugs Revenue Market Share by Country (2016-2021)
    Table 75. Asia Pacific Gastroesophageal Reflux Drugs Sales by Region (2016-2021) & (K Units)
    Table 76. Asia Pacific Gastroesophageal Reflux Drugs Sales Market Share by Region (2016-2021)
    Table 77. Asia Pacific Gastroesophageal Reflux Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 78. Asia Pacific Gastroesophageal Reflux Drugs Revenue Market Share by Region (2016-2021)
    Table 79. Europe Gastroesophageal Reflux Drugs Sales by Country (2016-2021) & (K Units)
    Table 80. Europe Gastroesophageal Reflux Drugs Sales Market Share by Country (2016-2021)
    Table 81. Europe Gastroesophageal Reflux Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Europe Gastroesophageal Reflux Drugs Revenue Market Share by Country (2016-2021)
    Table 83. Latin America Gastroesophageal Reflux Drugs Sales by Country (2016-2021) & (K Units)
    Table 84. Latin America Gastroesophageal Reflux Drugs Sales Market Share by Country (2016-2021)
    Table 85. Latin Americaa Gastroesophageal Reflux Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Latin America Gastroesophageal Reflux Drugs Revenue Market Share by Country (2016-2021)
    Table 87. Middle East and Africa Gastroesophageal Reflux Drugs Sales by Country (2016-2021) & (K Units)
    Table 88. Middle East and Africa Gastroesophageal Reflux Drugs Sales Market Share by Country (2016-2021)
    Table 89. Middle East and Africa Gastroesophageal Reflux Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 90. Middle East and Africa Gastroesophageal Reflux Drugs Revenue Market Share by Country (2016-2021)
    Table 91. Bayer Corporation Information
    Table 92. Bayer Description and Business Overview
    Table 93. Bayer Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 94. Bayer Gastroesophageal Reflux Drugs Product
    Table 95. Bayer Recent Development
    Table 96. Cadila Pharmaceuticals Corporation Information
    Table 97. Cadila Pharmaceuticals Description and Business Overview
    Table 98. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 99. Cadila Pharmaceuticals Product
    Table 100. Cadila Pharmaceuticals Recent Development
    Table 101. AstraZeneca Corporation Information
    Table 102. AstraZeneca Description and Business Overview
    Table 103. AstraZeneca Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 104. AstraZeneca Product
    Table 105. AstraZeneca Recent Development
    Table 106. Jiangsu Aosaikang Corporation Information
    Table 107. Jiangsu Aosaikang Description and Business Overview
    Table 108. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 109. Jiangsu Aosaikang Product
    Table 110. Jiangsu Aosaikang Recent Development
    Table 111. Eisai Corporation Information
    Table 112. Eisai Description and Business Overview
    Table 113. Eisai Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 114. Eisai Product
    Table 115. Eisai Recent Development
    Table 116. Pfizer Corporation Information
    Table 117. Pfizer Description and Business Overview
    Table 118. Pfizer Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 119. Pfizer Product
    Table 120. Pfizer Recent Development
    Table 121. Altana Pharma Corporation Information
    Table 122. Altana Pharma Description and Business Overview
    Table 123. Altana Pharma Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 124. Altana Pharma Product
    Table 125. Altana Pharma Recent Development
    Table 126. Takeda Corporation Information
    Table 127. Takeda Description and Business Overview
    Table 128. Takeda Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 129. Takeda Product
    Table 130. Takeda Recent Development
    Table 131. NCPC Corporation Information
    Table 132. NCPC Description and Business Overview
    Table 133. NCPC Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 134. NCPC Product
    Table 135. NCPC Recent Development
    Table 136. Luoxin Corporation Information
    Table 137. Luoxin Description and Business Overview
    Table 138. Luoxin Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 139. Luoxin Product
    Table 140. Luoxin Recent Development
    Table 141. Gastroesophageal Reflux Drugs Market Trends
    Table 142. Gastroesophageal Reflux Drugs Market Drivers
    Table 143. Gastroesophageal Reflux Drugs Market Challenges
    Table 144. Gastroesophageal Reflux Drugs Market Restraints
    Table 145. Gastroesophageal Reflux Drugs Customers List
    Table 146. Gastroesophageal Reflux Drugs Distributors List
    Table 147. Research Programs/Design for This Report
    Table 148. Key Data Information from Secondary Sources
    Table 149. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastroesophageal Reflux Drugs Product Picture
    Figure 2. Global Gastroesophageal Reflux Drugs Sales Market Share by Type in 2020 & 2027
    Figure 3. Esomeprazole Product Picture
    Figure 4. Lansoprazole Product Picture
    Figure 5. Omeprazole Product Picture
    Figure 6. Rbeprazole Product Picture
    Figure 7. Dexlansoprazole Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Gastroesophageal Reflux Drugs Sales Market Share by Application in 2020 & 2027
    Figure 10. Hospitals
    Figure 11. Ambulatory surgical centers
    Figure 12. Specialty clinics
    Figure 13. Others
    Figure 14. Gastroesophageal Reflux Drugs Report Years Considered
    Figure 15. Global Gastroesophageal Reflux Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 16. Global Gastroesophageal Reflux Drugs Market Size 2016-2027 (US$ Million)
    Figure 17. Global Gastroesophageal Reflux Drugs Sales 2016-2027 (K Units)
    Figure 18. Global Gastroesophageal Reflux Drugs Market Size Market Share by Region: 2021 Versus 2027
    Figure 19. Global Gastroesophageal Reflux Drugs Sales Market Share by Region (2016-2021)
    Figure 20. Global Gastroesophageal Reflux Drugs Sales Market Share by Region in 2020
    Figure 21. Global Gastroesophageal Reflux Drugs Revenue Market Share by Region (2016-2021)
    Figure 22. Global Gastroesophageal Reflux Drugs Revenue Market Share by Region in 2020
    Figure 23. Global Gastroesophageal Reflux Drugs Sales Share by Manufacturer in 2020
    Figure 24. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Drugs Revenue in 2020
    Figure 25. Gastroesophageal Reflux Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 26. Global Gastroesophageal Reflux Drugs Sales Market Share by Type (2016-2021)
    Figure 27. Global Gastroesophageal Reflux Drugs Sales Market Share by Type in 2020
    Figure 28. Global Gastroesophageal Reflux Drugs Revenue Market Share by Type (2016-2021)
    Figure 29. Global Gastroesophageal Reflux Drugs Revenue Market Share by Type in 2020
    Figure 30. Global Gastroesophageal Reflux Drugs Sales Market Share by Application (2016-2021)
    Figure 31. Global Gastroesophageal Reflux Drugs Sales Market Share by Application in 2020
    Figure 32. Global Gastroesophageal Reflux Drugs Revenue Market Share by Application (2016-2021)
    Figure 33. Global Gastroesophageal Reflux Drugs Revenue Market Share by Application in 2020
    Figure 34. Japan Gastroesophageal Reflux Drugs Sales Growth Rate 2016-2027 (K Units)
    Figure 35. Japan Gastroesophageal Reflux Drugs Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 36. Japan Gastroesophageal Reflux Drugs Market Share in Global Market 2016-2027
    Figure 37. Japan 5 and 10 Largest Gastroesophageal Reflux Drugs Players Market Share by Revenue in Gastroesophageal Reflux Drugs in 2020
    Figure 38. Japan Gastroesophageal Reflux Drugs Revenue Share by Type (2016-2021)
    Figure 39. Japan Gastroesophageal Reflux Drugs Revenue Growth Rate by Type in 2016 & 2020
    Figure 40. Japan Gastroesophageal Reflux Drugs Revenue Share by Application (2016-2021)
    Figure 41. Japan Gastroesophageal Reflux Drugs Revenue Growth Rate by Application in 2016 & 2020
    Figure 42. North America Gastroesophageal Reflux Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 43. North America Gastroesophageal Reflux Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 44. North America Gastroesophageal Reflux Drugs Sales Market Share by Country in 2020
    Figure 45. North America Gastroesophageal Reflux Drugs Revenue Market Share by Country in 2020
    Figure 46. U.S. Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 47. U.S. Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 48. Canada Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 49. Canada Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 50. Europe Gastroesophageal Reflux Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 51. Europe Gastroesophageal Reflux Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 52. Europe Gastroesophageal Reflux Drugs Sales Market Share by Country in 2020
    Figure 53. Europe Gastroesophageal Reflux Drugs Revenue Market Share by Country in 2020
    Figure 54. Germany Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 55. Germany Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 56. France Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 57. France Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. U.K. Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 59. U.K. Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 60. Italy Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 61. Italy Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 62. Russia Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 63. Russia Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 64. Asia Pacific Gastroesophageal Reflux Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 65. Asia Pacific Gastroesophageal Reflux Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 66. Asia Pacific Gastroesophageal Reflux Drugs Sales Market Share by Region in 2020
    Figure 67. Asia Pacific Gastroesophageal Reflux Drugs Revenue Market Share by Region in 2020
    Figure 68. China Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 69. China Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 70. Japan Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 71. Japan Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. South Korea Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 73. South Korea Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. India Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 75. India Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. Australia Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 77. Australia Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Taiwan Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 79. Taiwan Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. Indonesia Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 81. Indonesia Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 82. Thailand Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 83. Thailand Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 84. Malaysia Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 85. Malaysia Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 86. Philippines Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 87. Philippines Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 88. Vietnam Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 89. Vietnam Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 90. Latin America Gastroesophageal Reflux Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 91. Latin America Gastroesophageal Reflux Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 92. Latin America Gastroesophageal Reflux Drugs Sales Market Share by Country in 2020
    Figure 93. Latin America Gastroesophageal Reflux Drugs Revenue Market Share by Country in 2020
    Figure 94. Mexico Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 95. Mexico Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 96. Brazil Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 97. Brazil Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 98. Argentina Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 99. Argentina Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 100. Middle East and Africa Gastroesophageal Reflux Drugs Sales Growth Rate 2016-2021 (K Units)
    Figure 101. Middle East and Africa Gastroesophageal Reflux Drugs Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 102. Middle East and Africa Gastroesophageal Reflux Drugs Sales Market Share by Country in 2020
    Figure 103. Middle East and Africa Gastroesophageal Reflux Drugs Revenue Market Share by Country in 2020
    Figure 104. Turkey Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 105. Turkey Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 106. Saudi Arabia Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 107. Saudi Arabia Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 108. UAE Gastroesophageal Reflux Drugs Sales Growth Rate (2016-2021) (K Units)
    Figure 109. UAE Gastroesophageal Reflux Drugs Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 110. Gastroesophageal Reflux Drugs Value Chain
    Figure 111. Channels of Distribution
    Figure 112. Distributors Profiles
    Figure 113. Bottom-up and Top-down Approaches for This Report
    Figure 114. Data Triangulation
    Figure 115. Key Executives Interviewed